STADA ARZNEIMITTEL AG
ItalyAll drugs from this manufacturer
-
Hukyndra is indicated for the treatment of several inflammatory diseases, including rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, enthesitis-associated arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, non-infectious uveitis, and hidradenitis suppurativa.
Dosage form: solution for injection
Active substance Dosage adalimumab - ATC: L04AB04
-
It is used for the treatment of primary IgA nephropathy in adults aged 18 and older, acting on the intestine to reduce inflammation.
Dosage form: capsules, modified release, hard
Active substance Dosage budesonide - ATC: A07EA06
-
It is used to treat osteoporosis in adults, with the aim of making bones stronger and reducing the risk of fractures by stimulating their rebuilding.
Dosage form: solution for injection
Active substance Dosage teriparatide - ATC: H05AA02
-
Oyavas is used for the treatment of several types of cancer in adults, including colorectal cancer (colon or rectum), metastatic breast cancer, advanced non-small cell lung cancer, advanced renal cancer, advanced primary ovarian, fallopian tube, or peritoneal cancer, and cervical cancer.
Dosage form: solution for infusion, concentrate
Active substance Dosage bevacizumab - ATC: L01FG01
-
Tofidence is used to treat adults with moderate to severe active rheumatoid arthritis (RA) when previous therapies have not been sufficient. It is also indicated for adults with severe, active, and progressive rheumatoid arthritis not previously treated with methotrexate, for children over 2 years of age with systemic juvenile idiopathic arthritis (sJIA) or polyarticular juvenile idiopathic arthritis (pJIA), and for adults with COVID-19 who require oxygen therapy or mechanical ventilation and are receiving corticosteroid therapy.
Dosage form: solution for infusion, concentrate
Active substance Dosage tocilizumab - ATC: L04AC07
-
Usgena is used for the treatment of several inflammatory diseases, including plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), moderate to severe Crohn's disease (in adults), and moderate to severe ulcerative colitis (in adults).
Dosage form: solution for injection
Active substance Dosage ustekinumab - ATC: L04AC05
-
Uzpruvo is used for the treatment of certain inflammatory diseases, including plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), and moderate to severe Crohn's disease (in adults and children weighing at least 40 kg).
Dosage form: solution for injection in pre-filled syringe
Active substance Dosage ustekinumab - ATC: L04AC05
-
It is used in adults to treat various eye diseases that cause vision loss, such as age-related macular degeneration (AMD), proliferative diabetic retinopathy (PDR), diabetic macular edema (DME), and retinal vein occlusion (RVO).
Dosage form: solution for injection
Active substance Dosage ranibizumab - ATC: S01LA04